Literature DB >> 28748498

The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening.

Xabier García-Albéniz1,2, John Hsu3,4, Miguel A Hernán5,6,7.   

Abstract

Observational analyses for causal inference often rely on real world data collected for purposes other than research. A frequent goal of these observational analyses is to use the data to emulate a hypothetical randomized experiment, i.e., the target trial, that mimics the design features of a true experiment, including a clear definition of time zero with synchronization of treatment assignment and determination of eligibility. We review a recent observational analysis that explicitly emulated a target trial of screening colonoscopy using insurance claims from U.S. Medicare. We then compare this explicit emulation with alternative, simpler observational analyses that do not synchronize treatment assignment and eligibility determination at time zero and/or do not allow for repeated eligibility. This empirical comparison suggests that lack of an explicit emulation of the target trial leads to biased estimates, and shows that allowing for repeated eligibility increases the statistical efficiency of the estimates.

Entities:  

Keywords:  Causal inference; Colon cancer screening; Target trial

Mesh:

Year:  2017        PMID: 28748498      PMCID: PMC5759953          DOI: 10.1007/s10654-017-0287-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  12 in total

1.  The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer.

Authors:  M F Kaminski; M Bretthauer; A G Zauber; E J Kuipers; H-O Adami; M van Ballegooijen; J Regula; M van Leerdam; T Stefansson; L Påhlman; E Dekker; M A Hernán; K Garborg; G Hoff
Journal:  Endoscopy       Date:  2012-06-21       Impact factor: 10.093

2.  Does obesity shorten life? The importance of well-defined interventions to answer causal questions.

Authors:  M A Hernán; S L Taubman
Journal:  Int J Obes (Lond)       Date:  2008-08       Impact factor: 5.095

3.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

4.  Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.

Authors:  J H Scholefield; S M Moss; C M Mangham; D K Whynes; J D Hardcastle
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

Review 5.  Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.

Authors:  Miguel A Hernán; Brian C Sauer; Sonia Hernández-Díaz; Robert Platt; Ian Shrier
Journal:  J Clin Epidemiol       Date:  2016-05-27       Impact factor: 6.437

6.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

7.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Authors:  Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

Review 8.  Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Kimberly Andrews; Durado Brooks; Carol E DeSantis; Stacey A Fedewa; Joannie Lortet-Tieulent; Deana Manassaram-Baptiste; Otis W Brawley; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2016-01-21       Impact factor: 508.702

9.  Colorectal cancer mortality reduction is associated with having at least 1 colonoscopy within the previous 10 years among a population-wide cohort of screening age.

Authors:  David Stock; Lawrence F Paszat; Linda Rabeneck
Journal:  Gastrointest Endosc       Date:  2016-01-06       Impact factor: 9.427

10.  Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study.

Authors:  Xabier García-Albéniz; John Hsu; Michael Bretthauer; Miguel A Hernán
Journal:  Ann Intern Med       Date:  2016-09-27       Impact factor: 25.391

View more
  27 in total

1.  Novel methods for the analysis of stepped wedge cluster randomized trials.

Authors:  Lee Kennedy-Shaffer; Victor de Gruttola; Marc Lipsitch
Journal:  Stat Med       Date:  2019-12-26       Impact factor: 2.373

2.  Reflections From a Statistical Editor: Elements of Great Manuscripts.

Authors:  Miguel Marino
Journal:  Ann Fam Med       Date:  2017-11       Impact factor: 5.166

3.  How to estimate the effect of treatment duration on survival outcomes using observational data.

Authors:  Miguel A Hernán
Journal:  BMJ       Date:  2018-02-01

4.  The Critical Importance of Asking Good Questions: The Role of Epidemiology Doctoral Training Programs.

Authors:  Matthew P Fox; Jessie K Edwards; Robert Platt; Laura B Balzer
Journal:  Am J Epidemiol       Date:  2020-04-02       Impact factor: 4.897

5.  Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework.

Authors:  Sizheng Steven Zhao; Houchen Lyu; Daniel H Solomon; Kazuki Yoshida
Journal:  Ann Rheum Dis       Date:  2020-05-07       Impact factor: 19.103

6.  Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Authors:  Eleanor J Murray; Brandon D L Marshall; Ashley L Buchanan
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

7.  Exploring the feasibility of using real-world data from a large clinical data research network to simulate clinical trials of Alzheimer's disease.

Authors:  Zhaoyi Chen; Hansi Zhang; Yi Guo; Thomas J George; Mattia Prosperi; William R Hogan; Zhe He; Elizabeth A Shenkman; Fei Wang; Jiang Bian
Journal:  NPJ Digit Med       Date:  2021-05-14

8.  Complex systems models for causal inference in social epidemiology.

Authors:  Hiba N Kouser; Ruby Barnard-Mayers; Eleanor Murray
Journal:  J Epidemiol Community Health       Date:  2020-11-10       Impact factor: 3.710

9.  The Effect of Facility Volume on Survival Following Proctectomy for Rectal Cancer.

Authors:  Vanessa M Welten; Kerollos N Wanis; Arin L Madenci; Adam C Fields; Pamela W Lu; Robert A Malizia; James Yoo; Joel E Goldberg; Jennifer L Irani; Ronald Bleday; Nelya Melnitchouk
Journal:  J Gastrointest Surg       Date:  2021-07-21       Impact factor: 3.452

10.  Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.

Authors:  Minal K Patel; Isabel Bergeri; Joseph S Bresee; Benjamin J Cowling; Natasha S Crowcroft; Kamal Fahmy; Siddhivinayak Hirve; Gagandeep Kang; Mark A Katz; Claudio F Lanata; Maïna L'Azou Jackson; Sudhir Joshi; Marc Lipsitch; Jason M Mwenda; Francisco Nogareda; Walter A Orenstein; Justin R Ortiz; Richard Pebody; Stephanie J Schrag; Peter G Smith; Padmini Srikantiah; Lorenzo Subissi; Marta Valenciano; David W Vaughn; Jennifer R Verani; Annelies Wilder-Smith; Daniel R Feikin
Journal:  Vaccine       Date:  2021-06-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.